Convergence Financial’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$672K Sell
1,914
-62
-3% -$22.1K 0.07% 132
2025
Q4
$647K Sell
1,976
-27
-1% -$8.56K 0.09% 107
2025
Q3
$565K Buy
2,003
+442
+28% +$128K 0.08% 117
2025
Q2
$436K Buy
1,561
+277
+22% +$78.5K 0.07% 124
2025
Q1
$400K Buy
1,284
+268
+26% +$79.1K 0.08% 119
2024
Q4
$265K Buy
1,016
+382
+60% +$113K 0.05% 131
2024
Q3
$204K Buy
+634
New +$207K 0.04% 154

Other funds holding AMGN

Convergence Financial's AMGN Position: Q1 2026 in Review

Convergence Financial reduced its Amgen (AMGN) stake by 3.1% in Q1 2026, selling an estimated $22.1K and leaving 1,914 shares worth $672K. The position accounts for 0.07% of the portfolio, ranked #132.

Convergence Financial first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Convergence Financial held 1,914 shares of Amgen worth $672K as of Q1 2026.
  • Convergence Financial sold 62 Amgen shares in Q1 2026, an estimated $22.1K.
  • Amgen made up 0.07% of Convergence Financial's portfolio in Q1 2026, its #132 holding.
  • Convergence Financial first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Convergence Financial's 13F filing for Q1 2026, filed 11 May 2026.